These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 30380298)
1. Bioconjugation of Supramolecular Metallacages to Integrin Ligands for Targeted Delivery of Cisplatin. Han J; Räder AFB; Reichart F; Aikman B; Wenzel MN; Woods B; Weinmüller M; Ludwig BS; Stürup S; Groothuis GMM; Permentier HP; Bischoff R; Kessler H; Horvatovich P; Casini A Bioconjug Chem; 2018 Nov; 29(11):3856-3865. PubMed ID: 30380298 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of New Palladium Cages as Potential Delivery Systems for the Anticancer Drug Cisplatin. Schmidt A; Molano V; Hollering M; Pöthig A; Casini A; Kühn FE Chemistry; 2016 Feb; 22(7):2253-6. PubMed ID: 26756963 [TBL] [Abstract][Full Text] [Related]
3. Highly luminescent metallacages featuring bispyridyl ligands functionalised with BODIPY for imaging in cancer cells. Woods B; Döllerer D; Aikman B; Wenzel MN; Sayers EJ; Kühn FE; Jones AT; Casini A J Inorg Biochem; 2019 Oct; 199():110781. PubMed ID: 31357067 [TBL] [Abstract][Full Text] [Related]
4. Highly-fluorescent BODIPY-functionalised metallacages as drug delivery systems: synthesis, characterisation and cellular accumulation studies. Aikman B; Bonsignore R; Woods B; Doellerer D; Scotti R; Schmidt C; Heidecker AA; Pöthig A; Sayers EJ; Jones AT; Casini A Dalton Trans; 2022 May; 51(19):7476-7490. PubMed ID: 35470841 [TBL] [Abstract][Full Text] [Related]
5. RGD-modified polymeric micelles as potential carriers for targeted delivery to integrin-overexpressing tumor vasculature and tumor cells. Wang Y; Wang X; Zhang Y; Yang S; Wang J; Zhang X; Zhang Q J Drug Target; 2009 Jul; 17(6):459-67. PubMed ID: 19527117 [TBL] [Abstract][Full Text] [Related]
6. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides. Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773 [TBL] [Abstract][Full Text] [Related]
7. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer. Wang F; Chen L; Zhang R; Chen Z; Zhu L J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829 [TBL] [Abstract][Full Text] [Related]
8. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells. Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729 [TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac. Sudha T; Bharali DJ; Yalcin M; Darwish NH; Coskun MD; Keating KA; Lin HY; Davis PJ; Mousa SA Nanomedicine (Lond); 2017 Feb; 12(3):195-205. PubMed ID: 28102776 [TBL] [Abstract][Full Text] [Related]
11. Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor. Lee S; Kim J; Shim G; Kim S; Han SE; Kim K; Kwon IC; Choi Y; Kim YB; Kim CW; Oh YK J Control Release; 2012 Dec; 164(2):213-20. PubMed ID: 22664473 [TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer. He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315 [TBL] [Abstract][Full Text] [Related]
13. Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin. Falvo E; Tremante E; Fraioli R; Leonetti C; Zamparelli C; Boffi A; Morea V; Ceci P; Giacomini P Nanoscale; 2013 Dec; 5(24):12278-85. PubMed ID: 24150593 [TBL] [Abstract][Full Text] [Related]
14. Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma. Redko B; Tuchinsky H; Segal T; Tobi D; Luboshits G; Ashur-Fabian O; Pinhasov A; Gerlitz G; Gellerman G Oncotarget; 2017 Jan; 8(1):757-768. PubMed ID: 27768593 [TBL] [Abstract][Full Text] [Related]
15. Analytical strategies to study the formation and drug delivery capabilities of ferritin-encapsulated cisplatin in sensitive and resistant cell models. Turiel-Fernández D; Blanco-González E; Corte-Rodríguez M; Bettmer J; Montes-Bayón M Anal Bioanal Chem; 2020 Sep; 412(24):6319-6327. PubMed ID: 32185440 [TBL] [Abstract][Full Text] [Related]
16. Bioconjugation strategies to couple supramolecular exo-functionalized palladium cages to peptides for biomedical applications. Han J; Schmidt A; Zhang T; Permentier H; Groothuis GM; Bischoff R; Kühn FE; Horvatovich P; Casini A Chem Commun (Camb); 2017 Jan; 53(8):1405-1408. PubMed ID: 28079225 [TBL] [Abstract][Full Text] [Related]
17. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells. He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067 [TBL] [Abstract][Full Text] [Related]
18. Tetrac-decorated chitosan-coated PLGA nanoparticles as a new platform for targeted delivery of SN38. Alibolandi M; Amel Farzad S; Mohammadi M; Abnous K; Taghdisi SM; Kalalinia F; Ramezani M Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1003-1014. PubMed ID: 29806500 [TBL] [Abstract][Full Text] [Related]
19. Encapsulation of cisplatin in a pegylated calcium phosphate nanoparticle (CPNP) for enhanced cytotoxicity to cancerous cells. Ding Y; Zhai K; Pei P; Lin Y; Ma Y; Zhu H; Shao M; Yang X; Tao W J Colloid Interface Sci; 2017 May; 493():181-189. PubMed ID: 28092816 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization and in vivo evaluation of a magnetic cisplatin delivery nanosystem based on PMAA-graft-PEG copolymers. Voulgari E; Bakandritsos A; Galtsidis S; Zoumpourlis V; Burke BP; Clemente GS; Cawthorne C; Archibald SJ; Tuček J; Zbořil R; Kantarelou V; Karydas AG; Avgoustakis K J Control Release; 2016 Dec; 243():342-356. PubMed ID: 27793687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]